歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > CytoskeletalSignaling > Lifitegrast

瀏覽歷史

S81722

Lifitegrast

源葉(MedMol) 99%
  • 英文名:
  • Lifitegrast
  • 別名:
  • (S)-2-[2-(苯并呋喃-6-羰基)-5,7-二氯-1,2,3,4-四氫異喹啉-6-甲酰胺基]-3-(3-甲磺?;交?丙酸;SAR1118; Lifitegrast(SAR 1118); Lifitegrast;
  • CAS號:
  • 1025967-78-5
  • 分子式:
  • C29H24Cl2N2O7S
  • 分子量:
  • 615.4811
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
源葉(MedMol) S81722-1mg 99% ¥100.00元 3 - - - EA 加入購物車
源葉(MedMol) S81722-2mg 99% ¥180.00元 2 - - - EA 加入購物車
源葉(MedMol) S81722-5mg 99% ¥280.00元 4 - - - EA 加入購物車
源葉(MedMol) S81722-10mg 99% ¥320.00元 >10 - - - EA 加入購物車
源葉(MedMol) S81722-25mg 99% ¥370.00元 5 - - - EA 加入購物車
源葉(MedMol) S81722-50mg 99% ¥600.00元 5 - - - EA 加入購物車
源葉(MedMol) S81722-100mg 99% ¥1000.00元 5 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)(1篇)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Lifitegrast (SAR 1118) is a potent integrin antagonist. Lifitegrast blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast can be used for researching dry eye disease
  • 靶點(diǎn): αLβ2;Integrin
  • 體外研究:
    Lifitegrast (SAR 1118) inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), thus lessening overall inflammatory responses. Lifitegrast strongly inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM
  • 體內(nèi)研究:
    Lifitegrast (SAR 1118), has potent anti-inflammatory activity on corneal inflammation induced by antibiotic-killed P. aeruginosa and S. aureus in the presence of a silicone hydrogel lens with the optimal application being a 1% solution applied either 2 or 3 times prior. Lifitegrast (SAR 1118) ophthalmic drops administered thrice daily deliver therapeutic levels of Lifitegrast (SAR 1118) in the retina and can alleviate the retinal complications associated with diabetes
  • 參考文獻(xiàn):
    1. Perez VL, et al. Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease. Ocul Surf. 2016 Apr;14(2):207-15. 2. Sun Y, et al. Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118). J Ocul Pharmacol Ther. 2013 May;29(4):395-402. 3. Rao VR, et al. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin(STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5198-204.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.625 ml 8.124 ml 16.247 ml
    5 mM 0.325 ml 1.625 ml 3.249 ml
    10 mM 0.162 ml 0.812 ml 1.625 ml
    50 mM 0.032 ml 0.162 ml 0.325 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。